 |
|
|
|
|
 |
Last Updated: Nov 2, 2013 - 11:52:55 AM |
Latest Research
:
Cancer
:
Therapy
Taccalonolides from bat plants selectively kill cancer cells
In a new study published this month in the Journal of the American Chemical Society, researchers with The University of Texas Health Science Center at San Antonio have pinpointed the cancer-fighting potential in the bat plant, or Tacca chantrieri.
Nov 22, 2011 - 6:29:24 PM
|
Latest Research
:
Cancer
:
Therapy
Photodynamic therapy can help preserve the voice for patients with early stage laryngeal cancer
Light, or photodynamic, therapy can help preserve the voice and vocal cord function for patients with early stage laryngeal (voice box) cancer, according to a study from Henry Ford Hospital in Detroit.
Jan 29, 2011 - 10:05:10 PM
|
Latest Research
:
Cancer
:
Therapy
Bionic Nose to Detect Cancers
Washington, March 31 - Both cancer cells and chemicals used in bombs evade detection because they are present in very small quantities. But now a new method being developed can detect them by amplifying near invisible traces of biomarkers in cancer, materials in explosives or pollutants in water.
Mar 31, 2009 - 12:12:47 PM
|
Latest Research
:
Cancer
:
Therapy
Anti- cancer gene discovered- new strategy for treatment?
Starting with the tiny fruit fly, and then moving into mouse and human patients, researchers at VIB connected to the Center for Human Genetics (K.U. Leuven) showed that the same gene suppresses cancer in all three. Reciprocally, switching off the gene leads to cancer. The scientists think there is a good chance that the gene can be switched on again with a drug. They report their findings in the reputed scientific journal PLoS Biology.
Feb 25, 2009 - 12:48:17 AM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Anthracycline induced heart damage can be reduced by prolonging infusion time
Stretching out a dose of chemotherapy over six or more hours may reduce the risk of heart problems caused by certain commonly used cancer drugs, according to a new review of recent research.
Nov 23, 2006 - 9:41:49 AM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Genomic signatures to guide the use of chemotherapeutics
Scientists at Duke University's Institute for Genome Sciences & Policy have developed a panel of genomic tests that analyzes the unique molecular traits of a cancerous tumor and determines which chemotherapy will most aggressively attack that patient's cancer.
Oct 23, 2006 - 6:59:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
CDK2/FOXO1 as drug target to Prevent Tumors
Mayo Clinic researchers have found that a protein that initiates a "quality control check" during cell division also directs cell death for those cells damaged during duplication. This knowledge represents a potential "bulls eye" for targeting anti-tumor drugs. The findings appear in the current issue of Science.
Oct 13, 2006 - 1:11:00 AM
|
Latest Research
:
Cancer
:
Therapy
Telomerase inhibitors may revolutionize cancer therapy
A new target for cancer therapy has been identified by Monash University scientists investigating the cell signalling pathways that turn on a gene involved in cancer development.
Sep 21, 2006 - 8:19:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Vaccination
First ever shots of the cervical cancer vaccine administered in Queensland
UQ Professor Ian Frazer administered the first shots of the cervical cancer vaccine Gardasil in Queensland this afternoon at the Princess Alexandra Hospital.
Aug 29, 2006 - 3:41:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Gleevec can be toxic to the heart
Gleevec, the wildly successful poster-child of a new generation of cancer drugs aimed at specific targets in the cancer cell, can be dangerous to the heart. Not only that, but other similarly based drugs called tyrosine kinase inhibitors could lead to heart problems as well, say researchers at the Center for Translational Medicine at Jefferson Medical College in Philadelphia.
Jul 24, 2006 - 7:27:00 PM
|
Latest Research
:
Cancer
:
Therapy
Anti-cancer possibilities seen for certain monoamine oxidase inhibitors
In 2005, professor Ramin Shiekhattar, Ph.D., at The Wistar Institute and his colleagues reported details about an enzyme involved in appropriately repressing sets of neuronal genes in non-neuronal cells.
Jun 24, 2006 - 4:25:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
AS101 protects the testis from the effects of paclitaxel
It may be possible to protect the testes of cancer patients against the loss of fertility caused by chemotherapy, a scientist told the 22nd annual conference of the European Society of Human Reproduction and Embryology in Prague, Czech Republic on Tuesday 20 June 2006. Mr. Alon Carmely from Bar-Ilan University, Ramat Gan, Israel, said that his work showed for the first time that the injection of a drug that enhances the immune system could protect the testis from the effects of paclitaxel (Taxol), a widely used chemotherapy drug.
Jun 20, 2006 - 9:30:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Radiotherapy
Microbeam Radiation Therapy (MRT) Could Improve Cancer Treatment
Researchers at the U.S. Department of Energys Brookhaven National Laboratory and colleagues at Stony Brook University, the IRCCS NEUROMED Medical Center in Italy, and Georgetown University say improvements they have made to an experimental form of radiation therapy that has been under investigation for many years could make the technique more effective and eventually allow its use in hospitals. Results on the improved method, which was tested in rats, will be published online this week by the Proceedings of the National Academy of Sciences.
Jun 10, 2006 - 1:38:00 PM
|
Latest Research
:
Cancer
:
Therapy
Novel EGFR antibody mAb 806 targets tumors but not normal tissues
The Ludwig Institute for Cancer Research (LICR) and Life Science Pharmaceuticals (LSP) today announced the results of the first clinical trial of monoclonal antibody (mAb) 806, which demonstrate that 806 specifically targets epidermal growth factor receptor (EGFR) on a wide range of tumor types but has no uptake by normal tissues. This result is markedly different to other mAbs, which target wild-type (wt) EGFR on normal tissues.
Jun 6, 2006 - 2:41:00 PM
|
Latest Research
:
Cancer
:
Therapy
Oral chemotherapy option soon for cancer
Swiss pharmaceutical major Roche's study investigating Xeloda (capecitabine) in the first-line treatment of advanced stomach cancer has successfully met its primary endpoint, the company said Monday.
Apr 18, 2006 - 7:20:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Radiotherapy
Radiotherapy timings for colon cancer may need adjustments
Scientists have unexpectedly discovered that mice with the gene defect that causes colon cancer in humans can differ from normal mice in how they respond to radiation treatments. The large intestine carrying the gene defect in mice that received staggered doses of radiation was three to four times more resistant to the radiation than in control mice.
Apr 9, 2006 - 9:58:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Fibrasorb - New device that could cut chemotherapy deaths
A new method of delivering chemotherapy to cancer patients without incurring side effects such as hair loss and vomiting is being developed. The method, produced at the University of Bath, England, involves using tiny fibres and beads soaked in the chemotherapy drug which are then implanted into the cancerous area in the patient's body.
Apr 3, 2006 - 7:21:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Serendipity versus planning - cancer drugs of the future?
New anticancer drugs are usually developed specially for the job, but occasionally they are borrowed from another field of medicine, and applied speculatively in cancer. Tamoxifen was designed as an anti-oestrogen, based on the observation that at least a third of breast cancers depend on female sex hormones such as oestrogen for survival. Tamoxifen has shown to be an exceptionally effective molecule in cancer treatment; It was never planned to be a preventive agent, but so it has proved to be! It is now licensed to be used to prevent breast cancer in certain women at high risk of the disease.
Mar 27, 2006 - 4:29:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Vaccination
Scientists one step closer to cancer vaccine
Scientists at Karolinska Institutet in Sweden have helped to identify a molecule that can be used as a vaccination agent against growing cancer tumours. Although the results are so far based on animal experiments, they point to new methods of treating metastases.
Mar 22, 2006 - 1:42:00 AM
|
Latest Research
:
Cancer
:
Therapy
Possibility of Separating Anticancer Properties of Vitamin D Revealed
At the right dose, vitamin D is important for bone development and may help protect against the development of several cancers, particularly colorectal cancer. However, large quantities designed to exploit the vitamins anticancer properties can lead to a toxic overdose of calcium in the blood. Now, research done at Georgetown Universitys Lombardi Comprehensive Cancer Center indicates that it may be possible to separate the anticancer properties of vitamin D from its other functions.
Mar 19, 2006 - 8:49:00 PM
|
Latest Research
:
Cancer
:
Therapy
Vitamin D can be modified to produce only anti cancer effects
At the right dose, vitamin D is important for bone development and may help protect against the development of several cancers, particularly colorectal cancer. However, large quantities designed to exploit the vitamins anticancer properties can lead to a toxic overdose of calcium in the blood. Now, research done at Georgetown Universitys Lombardi Comprehensive Cancer Center indicates that it may be possible to separate the anticancer properties of vitamin D from its other functions.
Mar 18, 2006 - 2:07:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Sunitinib Approved for Gastrointestinal Stromal Tumors (GIST) and Kidney Cancer
The Food and Drug Administration (FDA) today announced approval of Sutent (sunitinib), a new targeted anti-cancer treatment for patients with gastrointestinal stromal tumors (GIST), a rare stomach cancer, and advanced kidney cancer. Today's action marks the first time the agency has approved a new oncology product for two indications simultaneously.
Jan 28, 2006 - 12:29:00 PM
|
Latest Research
:
Cancer
:
Therapy
AKT blocks cancer cell motility
In investigating the molecular mechanisms of cancer cell motility – the unique property that enables cancer to spread from its primary origin to other parts of the body – researchers have uncovered a surprising role for the AKT/PKB (protein kinase B) enzyme, providing important new insights into cancer metastasis and suggesting that current efforts to develop cancer therapies by inhibiting AKT may be inadvertently promoting the spread of the disease.
Nov 23, 2005 - 4:57:00 AM
|
Latest Research
:
Cancer
:
Therapy
Cetuximab to be Considered for the Treatment of Squamous Cell Carcinoma of the Head and Neck
ImClone Systems Incorporated and Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has notified ImClone Systems that it has accepted for filing the Company's supplemental Biologics License Application (sBLA) for ERBITUX(R) (Cetuximab), an IgG1 monoclonal antibody, in the treatment of Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Nov 1, 2005 - 2:18:00 AM
|
Latest Research
:
Cancer
:
Therapy
How antigen presenting cells are crucial to graft-versus-leukemia's cancer-killing effect
Researchers at the University of Michigan's Comprehensive Cancer Center have discovered the secret weapon behind the most powerful form of cancer immunotherapy known to medicine.
Oct 17, 2005 - 7:30:00 PM
|
Latest Research
:
Cancer
:
Therapy
Cranberry Compound Can Prevent Metastasis
Scientists have discovered a new compound in cranberries that works in a completely new way to prevent metastasis, the spread of cancer to other parts of the body.
Oct 17, 2005 - 7:25:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Vaccination
Response to Cancer Vaccine Enhanced by Chemotherapy
A study of a cancer vaccine in mice has found that the vaccine induces a tumor-specific immune response that is enhanced when used with chemotherapy regimens that include 5-fluorouracil (5-FU).
Oct 5, 2005 - 4:17:00 AM
|
Latest Research
:
Cancer
:
Therapy
Marine toxins can knock out the cancer cells
Vibrantly colored creatures from the depths of the South Pacific Ocean harbor toxins that potentially can act as powerful anti-cancer drugs, according to research findings from University of Wisconsin-Madison biochemists and their Italian colleagues.
Sep 28, 2005 - 7:59:00 AM
|
Latest Research
:
Cancer
:
Therapy
"Hitchhiking" Viruses as Cancer Drug Delivery System
A Mayo Clinic research team has devised a new virus-based gene therapy delivery system to help fight cancer. Researchers say their findings will help overcome hurdles that have hindered gene therapy cancer treatments.
Sep 19, 2005 - 12:40:00 PM
|
Latest Research
:
Cancer
:
Therapy
Pegfilgrastim Significantly Reduces the Incidence of Febrile Neutropenia
Amgen (Nasdaq: AMGN), the world's largest biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) approved an update to the Neulasta(R) (pegfilgrastim) prescribing information to include data from a landmark Phase 3 study demonstrating the white blood cell booster helps protect patients with most types of cancer undergoing moderately myelosuppressive chemotherapy from infection, as manifested by febrile neutropenia (low white blood cell count with fever), one of the most serious side effects of chemotherapy.
Sep 16, 2005 - 10:13:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Vaccination
Ligand Treatment of Treg Cells Enhanced Anti-Tumor Immunity
A special stretch of genetic material may turn off the immune suppression that stymies attempts to fight cancer with a vaccine, said researchers at Baylor College of Medicine (BCM) at Houston.
Sep 14, 2005 - 2:08:00 AM
|
Latest Research
:
Cancer
:
Therapy
Metallic Iron based Magnetic Nanoparticles for Potential New Cancer Treatment
Virginia Commonwealth University researchers have created highly magnetized nanoparticles based on metallic iron that could one day be used in a non-invasive therapy for cancer in which treatment would begin at the time of detection.
Sep 8, 2005 - 1:23:00 AM
|
Latest Research
:
Cancer
:
Therapy
Potential Cancer Treatment by Magnetic Nanoparticles
Virginia Commonwealth University researchers have created highly magnetized nanoparticles based on metallic iron that could one day be used in a non-invasive therapy for cancer in which treatment would begin at the time of detection.
Aug 30, 2005 - 8:05:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Celecoxib able to control chemotherapy resistant tumor cells
A close structural relative of the celebrated COX-2 inhibitor celecoxib (brand name: Celebrex) is a potent tumor fighter, able to wipe out tumor cells that are resistant to conventional chemotherapies, according to an interdisciplinary team of researchers from the University of Southern California.
Aug 30, 2005 - 7:23:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Inhibiting EAT-2 with medications could boost NK cell activity
Dr. André Veillette, a researcher at the Institut de recherches cliniques de Montréal (IRCM), and his team will publish in the upcoming issue of the prestigious journal Nature Immunology of Nature Publishing Group, a discovery that could significantly advance the treatment of cancers and infectious diseases. Current treatments frequently achieve only limited results with these types of diseases, which affect hundreds of thousands of Canadians.
Aug 29, 2005 - 10:57:00 PM
|
Latest Research
:
Cancer
:
Therapy
Cancer defense by manipulating energy regulation of cells
In an ongoing effort to fight disease by manipulating energy regulation of cells, a collaborative study led by Dartmouth Medical School (DMS) has demonstrated that cells lacking a tumor-suppressing kinase called LKB1 can still maintain healthy energy levels when they become stressed. This energy regulation is essential for keeping cells from dying off too quickly. The study's results could signal new advances for combating cancerous tumor growth, but also type 2 diabetes and obesity.
Aug 20, 2005 - 4:35:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Radiotherapy
Irradiation impairs reading development of young children
Largest study of its kind finds irradiation impairs reading development of young children even if they receive lower dose because they face an average risk of treatment failure
Aug 20, 2005 - 4:30:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Some Cancer Patients Treated With Cetuximab May Require Magnesium Supplementation
Some cancer patients being treated with cetuximab (Erbitux) may develop abnormally low blood levels of magnesium (hypomagnesemia) and require supplementation, according to a new study.
Aug 19, 2005 - 4:59:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Tie-1 significantly inhibits tumor progression in murine models
Dyax Corp. (Nasdaq: DYAX) announced today its presentation at the Drug Discovery Technology Conference (Boston Convention Center), highlighting the Company's discovery that antibody targeting of Tie-1 leads to the inhibition of primary tumor growth in murine models.
Aug 11, 2005 - 11:06:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Orphan Drug Application Filed for NOV-002 for Treating Refractory Ovarian Cancer
Novelos Therapeutics, Inc. (OTC BB: NVLT), a biotech company focusing on oxidized glutathione for use in fighting cancer and hepatitis, today announced that it has filed an orphan drug application with the U.S. FDA for the Company's lead compound, NOV-002. The application focuses on the investigation of combination therapy of NOV-002 with standard chemotherapy for treating refractory (chemotherapy resistant) ovarian cancer. A response from the FDA is expected by mid August.
Jun 17, 2005 - 9:56:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Treating 'chemobrain' by using dexmethyphenidate (d-MPH)
Patients who take medication for cancer often find themselves with a new problem when their treatment ends.
It's called "chemobrain," a common consequence of chemotherapy that causes memory problems, confusion and difficulty in concentrating.
Jun 8, 2005 - 1:00:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
A bioadhesive miconazole tablet is an effective way to treat oropharyngeal candidiasis
A bioadhesive tablet containing the antifungal drug miconazole is an effective and convenient means of treating oropharyngeal candidiasis, which is the most frequently occurring infection in head and neck cancer patients undergoing radiation therapy, scientists report today at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.
Jun 7, 2005 - 12:01:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
p53-based Targets as Novel Cancer Treatment Strategies
ADVEXIN(R) and INGN 225, investigational cancer therapies currently being evaluated in Phase 3 and Phase 2 trials, respectively, by Introgen Therapeutics, Inc. , were highlighted today in a special session, titled "The Clinical Trial Data on Ad-p53 Gene Therapy of Cancer" at the American Society of Gene Therapy 8th Annual Meeting (ASGT).
Jun 3, 2005 - 10:22:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Tarvacin Plus Docetaxel Significantly Inhibits Breast Tumor Growth
The published report shows that 3G4 (a murine equivalent of the company's Tarvacin(TM) monoclonal antibody) in combination with docetaxel results in a 93% inhibition of human breast cancer growth in mouse models. The researchers found that docetaxel increases the exposure of the 3G4 target on tumor blood vessels but not healthy tissue. Patient enrollment in a Tarvacin(TM) Phase 1 clinical trial for the treatment of all solid tumors, including breast cancer, is expected to commence this month at three clinical sites.
May 27, 2005 - 6:03:00 PM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Capecitabine as a Convenient Oral Treatment for Colon Cancer Patients
Data presented this week further strengthens the wealth of evidence showing that Xeloda(R) (capecitabine), an innovative oral chemotherapy, should replace the current standard treatment of intravenous 5-fluorouracil/leucovorin (i.v. 5-FU/LV) for colon cancer patients in the adjuvant (post-surgery) setting.
May 23, 2005 - 10:28:00 AM
|
Latest Research
:
Cancer
:
Therapy
LErafAON-ETU : a Liposome Entrapped c-raf Antisense Oligonucleotide for Advanced Cancer
NeoPharm (Nasdaq:NEOL) announced that preliminary Phase I clinical trial data for the Company's NeoLipid(TM) compound LErafAON-ETU was published in the American Society for Clinical Oncology (ASCO) Annual Meeting Proceedings. ASCO was held May 13-17, 2005 in Orlando, Florida.
May 21, 2005 - 10:42:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Vaccination
Prostate Cancer Vaccine gets Special Protocol Assessment by FDA
Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration (FDA) for its second Phase 3 clinical trial of GVAX(R) vaccine for prostate cancer. The SPA is a process that allows for official FDA evaluation of a Phase 3 clinical trial and provides trial sponsors with binding written agreement that the design and analysis of the study are adequate to support a license application submission if the study is performed according to the SPA.
May 19, 2005 - 9:35:00 AM
|
Latest Research
:
Cancer
:
Therapy
Gliadel® Wafer Plus Temozolomide Show Promising Results in High Grade Malignant Glioma
Guilford Pharmaceuticals Inc. today announced findings from a study of GLIADEL(R) Wafer (polifeprosan 20 with carmustine) and temozolomide used in combination to treat adult patients with newly diagnosed high grade malignant glioma. The data were presented at the 41st Annual Meeting of the American Society of Clinical Oncology in Orlando, FL.
May 18, 2005 - 9:58:00 AM
|
Latest Research
:
Cancer
:
Therapy
:
Pharmacotherapy
Gemcitabine Based Regimens Improve Quality of Life in Non-Small Cell Lung Cancer
Data presented today(1,2,3) from ongoing clinical trials show that therapies based on Eli Lilly and Company's (LLY) Gemzar(R) (gemcitabine, HCl) administered prior to surgery have a positive impact on survival, tumor shrinkage and quality of life among patients with early-stage non-small cell lung cancer (NSCLC).
May 18, 2005 - 9:49:00 AM
|
Latest Research
:
Cancer
:
Therapy
Velafermin Shows Promising Results in Prevention of Chemotherapy Induced Oral mucositis
The final results from this Phase I study suggest velafermin (CG53135) is well tolerated following intravenous administration with data supporting the Company's ongoing Phase II trial and strategy of investigating a single-dose of velafermin (CG53135) for the prevention of oral mucositis (OM).
May 18, 2005 - 9:37:00 AM
|
|
|
|
|
| Health |
Gathering information about food is not top priority for individuals with high metabolisms
|
NIH renews funding for University of Maryland vaccine research
|
DHA-enriched formula in infancy linked to positive cognitive outcomes in childhood
|
New IOM report lays out plan to determine effectiveness of obesity prevention efforts
|
Vitamin D supplementation may delay precocious puberty in girls
|
Study: Pedometer program helps motivate participants to sit less, move more
|
Fish oil may stall effects of junk food on brain
|
Intake of low energy dense food better than skipping meals
|
Inaugural IOF Olof Johnell Science Award presented to Professor Harry Genant
|
Molecular hub links obesity, heart disease to high blood pressure
|
| | Healthcare |
Healthcare experts from UK and India meet at the UK Parliament to discuss ways to improve health care in India, UK
|
Flu pandemic infected one in five
|
Stigma preventing leprosy-cured from getting jobs
|
Measles, Mumps make a comeback in US
|
Melinda Gates calls on Akhilesh Yadav
|
'Movies, TV impact tobacco users more than newspapers'
|
Rockland to open three new hospitals in NCR
|
Spice Global enters healthcare business with hospital in Delhi
|
Delhi to expedite recruitment of doctors
|
India adds spice to US life, keeps it healthy
|
| | Latest Research |
How do consumers see a product when they hear music?
|
Drug activates virus against cancer
|
Bone loss associated with increased production of ROS
|
Sound preconditioning prevents ototoxic drug-induced hearing loss in mice
|
Crystal methamphetamine use by street youth increases risk of injecting drugs
|
Johns Hopkins-led study shows increased life expectancy among family caregivers
|
Moderate to severe psoriasis linked to chronic kidney disease, say experts
|
Licensing deal marks coming of age for University of Washington, University of Alabama-Birmingham
|
Simple blood or urine test to identify blinding disease
|
Physician job satisfaction driven by quality of patient care
|
| | Medical News |
NHRC issues notice to Kerala over infant deaths
|
Advanced breast cancer detecting machine comes to India
|
'Dispel myths about vitiligo'
|
NHRC summons Odisha chief secretary
|
Woman dies of swine flu in UP
|
Maharashtra, GE to modernise rural health care
|
Hypertension: India's silent killer
|
Need cautious effort to eradicate polio: Experts
|
Ayurveda experts develop online personalised health regimen
|
Soon a detailed study on 'diabesity': Doctors
|
| | Special Topics |
MPs express anguish at Delhi gang-rape, Shinde assures fast trial
|
Worrying rise in number of medical students in prostitution over last 10 years
|
Behold India's unfolding democratic revolution
|
Chinese woman cuts open her belly to save surgery cost
|
Improved Sense of Smell Produced Smarter Mammals
|
Two-year-old world's first to have extra DNA strand
|
172,155 kidney stones removed from one patient!
|
'Primodial Soup' theory for origin of life rejected in paper
|
Human species could have killed Neanderthal man
|
History, geography also seem to shape our genome
|
|
|
